Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was up 1.9% during mid-day trading on Thursday . The stock traded as high as $57.57 and last traded at $57.57. Approximately 628 shares changed hands during trading, a decline of 38% from the average daily volume of 1,018 shares. The stock had previously closed at $56.51.
Hikma Pharmaceuticals Stock Performance
The stock has a 50 day moving average price of $50.74 and a 200-day moving average price of $50.40.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- High Dividend REITs: Are They an Ideal Way to Diversify?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Dividend Payout Ratio Calculator
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
